These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 33533684

  • 21. Plasma proatrial natriuretic peptide associates with lipid oxidation during exercise and cardiorespiratory fitness in healthy young adults.
    Thomsen CF, Ried-Larsen M, Goetze JP, Andersen LB, Faber J, Grøntved A, Jeppesen JL.
    Peptides; 2019 Dec; 122():170156. PubMed ID: 31550524
    [Abstract] [Full Text] [Related]

  • 22. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 23. Mid-regional plasma pro-atrial natriuretic peptide and stroke volume responsiveness for detecting deviations in central blood volume following major abdominal surgery.
    Strandby RB, Secher NH, Ambrus R, Gøtze JP, Henriksen A, Kitchen CC, Achiam MP, Svendsen LB.
    Acta Anaesthesiol Scand; 2022 Oct 13; 66(9):1061-1069. PubMed ID: 36069352
    [Abstract] [Full Text] [Related]

  • 24. Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography.
    Metry G, Hall C, Wikström B, Källskog V, Hansell P, Danielson B.
    Acta Physiol Scand; 2001 Feb 13; 171(2):117-22. PubMed ID: 11350271
    [Abstract] [Full Text] [Related]

  • 25. Long-term exposure to intermittent hypoxia results in increased hemoglobin mass, reduced plasma volume, and elevated erythropoietin plasma levels in man.
    Heinicke K, Prommer N, Cajigal J, Viola T, Behn C, Schmidt W.
    Eur J Appl Physiol; 2003 Feb 13; 88(6):535-43. PubMed ID: 12560952
    [Abstract] [Full Text] [Related]

  • 26. [Effects of acute and protracted hypoxia on plasma levels of atrial natriuretic factor].
    De Angelis C, Farrace S, Urbani L, Porcù S, Ferri C, D'Amelio R, Santucci A.
    Cardiologia; 1992 Feb 13; 37(2):117-21. PubMed ID: 1534709
    [Abstract] [Full Text] [Related]

  • 27. Paradoxical relationship between N-terminal proatrial natriuretic peptide and filling pressure in adults with cyanotic congenital heart disease.
    Hopkins WE, Hall C.
    Circulation; 1997 Oct 07; 96(7):2215-20. PubMed ID: 9337192
    [Abstract] [Full Text] [Related]

  • 28. Fetal hypoxia elevates plasma atrial natriuretic factor concentration.
    Cheung CY, Brace RA.
    Am J Obstet Gynecol; 1988 Nov 07; 159(5):1263-8. PubMed ID: 2973236
    [Abstract] [Full Text] [Related]

  • 29. Atrial plasma ANP and NH2-terminal proANP during right atrial pressure increase in humans.
    Arjamaa O, Karlqvist K, Vainionpää V, Leppäluoto J, Vuolteenaho O.
    Acta Physiol Scand; 1996 Aug 07; 157(4):481-5. PubMed ID: 8869731
    [Abstract] [Full Text] [Related]

  • 30. Effects of changes in intravascular volume on atrial size and plasma levels of immunoreactive atrial natriuretic peptide in uremic man.
    Cannella G, Albertini A, Assanelli D, Ghielmi S, Poiesi C, Gaggiotti M, Sandrini M, Visioli O, Maiorca R.
    Clin Nephrol; 1988 Oct 07; 30(4):187-92. PubMed ID: 2975201
    [Abstract] [Full Text] [Related]

  • 31. Midregional pro-A-type natriuretic peptide and carboxy-terminal provasopressin may predict prognosis in community-acquired pneumonia.
    Masiá M, Papassotiriou J, Morgenthaler NG, Hernández I, Shum C, Gutiérrez F.
    Clin Chem; 2007 Dec 07; 53(12):2193-201. PubMed ID: 17951293
    [Abstract] [Full Text] [Related]

  • 32. Atrial natriuretic peptide during and after maximal and submaximal exercise under normoxic and hypoxic conditions.
    Schmidt W, Brabant G, Kröger C, Strauch S, Hilgendorf A.
    Eur J Appl Physiol Occup Physiol; 1990 Dec 07; 61(5-6):398-407. PubMed ID: 2150372
    [Abstract] [Full Text] [Related]

  • 33. NT-proANP and BNP in renovascular and in severe and mild essential hypertension.
    Mussalo H, Vanninen E, Ikäheimo R, Hartikainen J.
    Kidney Blood Press Res; 2003 Dec 07; 26(1):34-41. PubMed ID: 12697975
    [Abstract] [Full Text] [Related]

  • 34. Effect of adrenaline on serum mid-regional pro-atrial natriuretic peptide and central blood volume.
    Sejersen C, Bjerre-Bastos JJ, Goetze JP, Nielsen HB, Bihlet AR, Secher NH.
    Exp Physiol; 2022 Sep 07; 107(9):1037-1045. PubMed ID: 35912634
    [Abstract] [Full Text] [Related]

  • 35. Midregional proatrial natriuretic peptide predicts survival in exacerbations of COPD.
    Bernasconi M, Tamm M, Bingisser R, Miedinger D, Leuppi J, Müller B, Christ-Crain M, Stolz D.
    Chest; 2011 Jul 07; 140(1):91-99. PubMed ID: 21106656
    [Abstract] [Full Text] [Related]

  • 36. The prognostic value of midregional proatrial natriuretic peptide in patients with hemorrhagic stroke.
    Fischer M, Katan M, Morgenthaler NG, Seiler M, Müller B, Lackner P, Errath M, Helbok R, Pfausler B, Beer R, Schmutzhard E, Broessner G.
    Cerebrovasc Dis; 2014 Jul 07; 37(2):128-33. PubMed ID: 24481415
    [Abstract] [Full Text] [Related]

  • 37. Fluid-regulatory hormone responses during cycling exercise in acute hypobaric hypoxia.
    Bocqueraz O, Koulmann N, Guigas B, Jimenez C, Melin B.
    Med Sci Sports Exerc; 2004 Oct 07; 36(10):1730-6. PubMed ID: 15595294
    [Abstract] [Full Text] [Related]

  • 38. Independent effect of atrial fibrillation on natriuretic peptide release.
    Sramko M, Wichterle D, Melenovsky V, Franekova J, Clemens M, Fukunaga M, Kautzner J.
    Clin Res Cardiol; 2019 Feb 07; 108(2):142-149. PubMed ID: 30051184
    [Abstract] [Full Text] [Related]

  • 39. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment.
    Franz M, Woloszczuk W, Hörl WH.
    Kidney Int; 2000 Jul 07; 58(1):374-83. PubMed ID: 10886584
    [Abstract] [Full Text] [Related]

  • 40. Natriuretic Propeptides as Markers of Atrial Fibrillation Burden and Recurrence (from the AMIO-CAT Trial).
    Darkner S, Goetze JP, Chen X, Henningsen K, Pehrson S, Svendsen JH.
    Am J Cardiol; 2017 Oct 15; 120(8):1309-1315. PubMed ID: 28865890
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.